Article Information
History
- March 26, 2021.
Article Versions
- You are currently viewing Version 1 of this article (March 26, 2021 - 11:36).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Fredy Suter, MD1,
- Elena Consolaro, MD2,
- Stefania Pedroni, MD2,
- Chiara Moroni, MD2,
- Elena Pastò, MD2,
- Maria Vittoria Paganini, MD2,
- Grazia Pravettoni, MD3,
- Umberto Cantarelli, MD4,
- Nadia Rubis, RES NURSE5,
- Norberto Perico, MD*,5,†,
- Annalisa Perna, MSC5,
- Tobia Peracchi, STATSCID5,
- Piero Ruggenenti, MD*,1,5 and
- Giuseppe Remuzzi, MD*,5
- 1Azienda Socio-Sanitaria Territoriale (ASST) Papa Giovanni XXIII, Bergamo, Italy
- 2ATS Insubria, Varese, Italy
- 3Ospedale Circolo di Busto Arsizio, Varese, Italy
- 4ASL Teramo, Teramo, Italy
- 5Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy
- ↵†Correspondence to: Norberto Perico MD, Istituto di Ricerche Farmacologiche IRCCS, Centro di Ricerche Cliniche per Malattie Rare Aldo e Cele Daccò, Via GB Camozzi 3, 24020 Ranica, Bergamo, Italy., Email: norberto.perico{at}marionegri.it
↵* equally contributed